Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges
| 대상 질환 | Alzheimer Disease, Mild Cognitive Impairment, Dementia |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Brigham and Women's Hospital |
| 상태 | 완료 |
| 참여자 수 | 262 명 |
| 중재(약물) | Nudge Intervention |
| 시작일 | 2024년 8월 1일 |
| 완료일 | 2025년 10월 14일 |
| 결과 공개일 | 2026년 7월 30일 |
요약
The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.
Composite of the Percentage of Eligible PCPs or Their PLWD/Care Partners Who View or Click on Information on or Before the Primary Care Provider Visit, up to 10 Days
| Nudge Intervention | 103 Participants |
|---|
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University